SoftBank-backed Guardant Health raises $238m in US IPO

Pedestrians walk past a SoftBank Group Corp. store in Tokyo, Japan. Photographer: Tomohiro Ohsumi

Guardant Health Inc., a cancer-detection firm backed by SoftBank Group Corp., raised $237.5 million in its U.S. initial public offering.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.